Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 88.0
(0.19%)
INR 88.0
(0.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 37.76 Million INR | -27.96% |
| 2022 | 52.42 Million INR | -21.32% |
| 2021 | 66.62 Million INR | 93.08% |
| 2020 | 34.5 Million INR | 35.1% |
| 2019 | 25.54 Million INR | 412.12% |
| 2018 | 4.98 Million INR | 237.02% |
| 2017 | -3.63 Million INR | -105.63% |
| 2016 | 64.59 Million INR | -2.96% |
| 2015 | 66.57 Million INR | 4.87% |
| 2014 | 63.48 Million INR | -16.56% |
| 2013 | 76.08 Million INR | 2.86% |
| 2012 | 73.96 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 893 Thousand INR | -98.41% |
| 2023 Q1 | 52.42 Million INR | 249.3% |
| 2023 Q2 | 20.29 Million INR | -61.28% |
| 2023 Q3 | 56.19 Million INR | 176.82% |
| 2023 FY | 37.76 Million INR | -27.96% |
| 2022 Q4 | 15 Million INR | -80.36% |
| 2022 FY | 52.42 Million INR | -21.32% |
| 2022 Q1 | 66.62 Million INR | 1160.19% |
| 2022 Q2 | 15.09 Million INR | -77.35% |
| 2022 Q3 | 76.39 Million INR | 406.22% |
| 2021 Q1 | 34.5 Million INR | 660.08% |
| 2021 FY | 66.62 Million INR | 93.08% |
| 2021 Q2 | 12.86 Million INR | -62.72% |
| 2021 Q3 | 35.78 Million INR | 178.16% |
| 2021 Q4 | 5.28 Million INR | -85.22% |
| 2020 FY | 34.5 Million INR | 35.1% |
| 2020 Q4 | 4.54 Million INR | -85.93% |
| 2020 Q3 | 32.26 Million INR | 7627.76% |
| 2020 Q2 | 417.46 Thousand INR | -98.37% |
| 2020 Q1 | 25.54 Million INR | 1935.2% |
| 2019 Q2 | 1.82 Million INR | -63.37% |
| 2019 Q1 | 4.98 Million INR | -44.22% |
| 2019 FY | 25.54 Million INR | 412.12% |
| 2019 Q4 | 1.25 Million INR | -93.99% |
| 2019 Q3 | 20.88 Million INR | 1042.91% |
| 2018 Q2 | 7.32 Million INR | 286.91% |
| 2018 Q1 | -3.92 Million INR | 0.0% |
| 2018 FY | 4.98 Million INR | 237.02% |
| 2018 Q3 | 14.38 Million INR | 96.34% |
| 2018 Q4 | 8.94 Million INR | -37.85% |
| 2017 FY | -3.63 Million INR | -105.63% |
| 2017 Q1 | 64.59 Million INR | 1009.93% |
| 2017 Q2 | 5.33 Million INR | -91.74% |
| 2017 Q3 | 8.12 Million INR | 52.22% |
| 2016 Q3 | 58.85 Million INR | 0.0% |
| 2016 Q1 | 66.57 Million INR | 658.3% |
| 2016 Q4 | 5.82 Million INR | -90.11% |
| 2016 FY | 64.59 Million INR | -2.96% |
| 2015 Q1 | 62.31 Million INR | 778.94% |
| 2015 FY | 66.57 Million INR | 4.87% |
| 2015 Q4 | 8.77 Million INR | -88.42% |
| 2015 Q2 | 18.62 Million INR | -70.12% |
| 2015 Q3 | 75.81 Million INR | 307.11% |
| 2014 Q3 | 24.65 Million INR | 117.67% |
| 2014 Q4 | 7.09 Million INR | -71.24% |
| 2014 FY | 63.48 Million INR | -16.56% |
| 2014 Q1 | 74.76 Million INR | 295.22% |
| 2014 Q2 | 11.32 Million INR | -84.85% |
| 2013 Q1 | 72.49 Million INR | 0.0% |
| 2013 FY | 76.08 Million INR | 2.86% |
| 2013 Q2 | 16.91 Million INR | -76.66% |
| 2013 Q4 | 18.91 Million INR | -74.07% |
| 2013 Q3 | 72.96 Million INR | 331.28% |
| 2012 FY | 73.96 Million INR | 0.0% |
| 2012 Q3 | 115.05 Million INR | 0.0% |
| 2010 Q1 | 26.27 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | -49.778% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 91.253% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 184.627% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 149.59% |
| Sunil Healthcare Limited | 625.4 Million INR | 93.962% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 723.374% |
| MedPlus Health Services Limited | 8.67 Billion INR | 99.565% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 94.522% |
| Patidar Buildcon Limited | 25.12 Million INR | -50.298% |
| Roopa Industries Limited | 216.01 Million INR | 82.518% |
| Smruthi Organics Limited | 111.28 Million INR | 66.067% |
| Trident Lifeline Limited | 117.56 Million INR | 67.877% |
| PANJON LTD. | -12.8 Million INR | 394.847% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -1.277% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -180.878% |
| Anuh Pharma Limited | -69.8 Million INR | 154.098% |
| Crestchem Limited | -1.45 Million INR | 2704.414% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 162.181% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 430.394% |
| Tyche Industries Limited | -788.94 Million INR | 104.787% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 96.383% |
| Trimurthi Limited | -1.17 Million INR | 3305.228% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 155.32% |
| Norris Medicines Limited | 214.86 Million INR | 82.424% |
| Zenlabs Ethica Limited | 139.54 Million INR | 72.938% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 2.229% |
| ANG Lifesciences India Limited | 671.01 Million INR | 94.372% |
| Parmax Pharma Limited | 51.8 Million INR | 27.11% |
| Veerhealth Care Limited | -2.38 Million INR | 1683.396% |
| Deccan Health Care Limited | -7.07 Million INR | 633.691% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 96.393% |
| Makers Laboratories Limited | 172.59 Million INR | 78.119% |
| Lactose (India) Limited | 373.97 Million INR | 89.902% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 93.39% |
| Zenith Healthcare Limited | -25.45 Million INR | 248.344% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 143.937% |
| Bacil Pharma Limited | 569 Thousand INR | -6536.907% |
| PRAVEG LIMITED | -434.98 Million INR | 108.682% |
| Denis Chem Lab Limited | -236.28 Million INR | 115.982% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 95.903% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 104.769% |
| Colinz Laboratories Limited | -64.3 Million INR | 158.728% |
| Godavari Drugs Limited | 530.02 Million INR | 92.875% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 505.628% |
| Zenotech Laboratories Limited | -196.85 Million INR | 119.183% |
| Panchsheel Organics Limited | -157.82 Million INR | 123.928% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 81.292% |
| Vivanza Biosciences Limited | 50.02 Million INR | 24.511% |
| Phaarmasia Limited | -4.89 Million INR | 871.166% |
| Sastasundar Ventures Limited | -297.24 Million INR | 112.705% |
| Medi-Caps Limited | -3.21 Million INR | 1274.984% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 140.546% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 170.084% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 71.413% |
| Mercury Laboratories Limited | -26.72 Million INR | 241.285% |
| Gennex Laboratories Limited | -552.54 Million INR | 106.835% |
| BDH Industries Limited | -164.47 Million INR | 122.961% |
| Coral Laboratories Limited | -612.82 Million INR | 106.162% |
| Concord Drugs Limited | 164.48 Million INR | 77.041% |
| Bharat Parenterals Limited | 1.48 Billion INR | 97.463% |
| Beryl Drugs Limited | 48.7 Million INR | 22.469% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 52.018% |
| Evoq Remedies Limited | 41.14 Million INR | 8.224% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 67.514% |
| Transchem Limited | -3.16 Million INR | 1293.93% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 178.515% |
| Parnax Lab Limited | 787.61 Million INR | 95.205% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 164.459% |
| Kerala Ayurveda Limited | 447.82 Million INR | 91.567% |
| Cian Healthcare Limited | 544.97 Million INR | 93.07% |
| Trinity League India Limited | -12 Thousand INR | 314800.0% |
| Syschem (India) Limited | 3.53 Million INR | -969.196% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 97.293% |
| Natural Capsules Limited | 956.68 Million INR | 96.053% |
| Auro Laboratories Limited | 252.51 Million INR | 85.045% |